The overall goal of this educational session is to be able to recognize the importance of managing overweight/obesity as a comorbid condition for their cardiology patients and discuss the use and effectiveness of anti-obesity medications (AOMs) when developing weight management plans to improve cardiovascular health.
Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation Statement:
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Credit Designation Statement:
Physicians:
The ACCF designates this internet enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses:
The ACCF designates this educational activity for a maximum of 1.25 continuing nursing education contact hours.
Physician Associates:
AAPA Credit Designation Statement – Enduring Materials
The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 04/18/2026 PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education (ICPE) Credit:
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
Target Audience:
This course is intended for physicians, nurses, physician associates and the cardiovascular care team.
Important Dates:
Date of Release: April 30, 2025
Term of Approval/Date of Expiration: April 30, 2026
Learner Objectives:
Upon completion of this program, attendees should be able to:
- Discuss the challenges of overall cardiology care in the presence of comorbid conditions such as obesity, diabetes, and heart failure, and other patient considerations.
- Identify current and emerging anti-obesity medications (AOMs) and their role in improving cardiovascular health.
- Develop appropriate weight-management care plans that include lifestyle interventions and pharmacologic strategies such as AOMs.
- Consider the roles and responsibilities of the cardiology interprofessional care team when managing patients with obesity.
Grant Acknowledgement:
Educational grant support for this activity provided by Novo Nordisk.
Faculty
Leslie Cho, MD, FACC
Abraham Michael Lincoff, MD, FACC
Pam R. Taub, MD, FACC
Amanda Vest, MD, FACC
Martine Altieri, PA-C
Planning Committee
Leslie Cho, MD, FACC
Abraham Michael Lincoff, MD, FACC
Pam R. Taub, MD, FACC
Amanda Vest, MD, FACC
Martine Altieri, PA-C
Chris Owen, MS, ACNP-BC, AAC